Shan-shan Song

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

UBA3 reduction sensitizes cancer cells to NAE inhibitors.

UBA3 reduction sensitizes cancer cells to NAE inhibitors.

Journal: Life science alliance

Published: December 04, 2025

PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors.

PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors.

Journal: Molecular biomedicine

Published: August 28, 2025

Effects of short-term fencing on plant functional diversity in the meadow steppe of Saihanba, Hebei Pro-vince, China.

Effects of short-term fencing on plant functional diversity in the meadow steppe of Saihanba, Hebei Pro-vince, China.

Journal: Ying yong sheng tai xue bao = The journal of applied ecology

Published: May 16, 2025

Combination of Cbl-b inhibitor NX-1607 and CDK4/6 inhibitor abemaciclib enhances anti-tumor immunity through PLCγ1/ERK-mediated T cell activation.

Combination of Cbl-b inhibitor NX-1607 and CDK4/6 inhibitor abemaciclib enhances anti-tumor immunity through PLCγ1/ERK-mediated T cell activation.

Journal: Cellular signalling

Published: March 10, 2025

UBE4B modulates BET inhibitor sensitivity via KLHL22-JAK2-PIM1 axis in hepatocellular carcinoma.

UBE4B modulates BET inhibitor sensitivity via KLHL22-JAK2-PIM1 axis in hepatocellular carcinoma.

Journal: Biochemical pharmacology

Published: November 19, 2024

The combination of BET and METTL3 inhibitors elicits synergistic antitumor effects in ovarian cancer cells via reducing SP1 and BCL-2 expression.

The combination of BET and METTL3 inhibitors elicits synergistic antitumor effects in ovarian cancer cells via reducing SP1 and BCL-2 expression.

Journal: Life sciences

Published: October 05, 2024

USP7 V517F mutation as a mechanism of inhibitor resistance.

USP7 V517F mutation as a mechanism of inhibitor resistance.

Journal: Nature communications

Published: August 12, 2024

Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy.

Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy.

Journal: European journal of medicinal chemistry

Published: June 27, 2024

The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity.

The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity.

Journal: Biochemical and biophysical research communications

Published: March 12, 2024

Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy.

Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy.

Journal: Biochemical pharmacology

Published: December 28, 2023

Effects of electroacupuncture on the glucose-lipid metabolism and the expression of ZAG and GLUT4 in the femoral quadriceps and adipose tissue in the rats with type 2 diabetes mellitus.

Effects of electroacupuncture on the glucose-lipid metabolism and the expression of ZAG and GLUT4 in the femoral quadriceps and adipose tissue in the rats with type 2 diabetes mellitus.

Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion

Published: December 13, 2023

Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy.

Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy.

Journal: Biochemical pharmacology

Published: December 11, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026